Home › Insider buying › ORMP

Oramed Pharmaceuticals Inc. (ORMP): insider trading, Congress trades & who owns it

By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Insider signal
30/100
Insider selling · 90 days
Insider buys
$0
0 buyers · 12 months
Insider sales
$1.2M
2 sellers · 12 months
Funds holding
84
13F · Q2 2026
Congress trades
1
1 member · 2 years

Oramed Pharmaceuticals Inc. officers and board members have only been selling lately: two insiders reduced their stakes by about $1.2 million of stock over 12 months, with no open-market purchases.

Selling on its own is common and often pre-planned (10b5-1 plans, taxes, diversification), so it matters more when it is unusually heavy or broad.

Members of Congress reported 1 trade in ORMP over the past two years (one member). Quarter by quarter: Last full quarter: net selling by insiders. Insiders bought in 0 of the last 7 full quarters. On the institutional side, 84 funds reported holding ORMP at the end of Q2 2026, and more funds bought than sold.

Want the full picture on ORMP? Financials, dilution history, a written bull & bear case, top holders and alerts.
See the full ORMP report — free account

Latest insider trades in ORMP

FiledInsiderRoleTypeSharesPriceValueSource
Oct 2, 2026Gabay AvrahamCFOSell20,000$4.51$90KSEC
Oct 2, 2026Hexter JoshuaCOOSell30,000$4.51$135KSEC
Jul 2, 2026Hexter JoshuaCOOSell137,000$4.46$611KSEC
Jul 2, 2026Gabay AvrahamCFOSell73,360$4.51$331KSEC
Apr 4, 2023Mayer ArieDirectorBuy3,800$2.21$8KSEC
Apr 4, 2023Mayer ArieDirectorBuy5,009$2.22$11KSEC
Mar 16, 2023KIDRON NADAVCEOBuy26,000$2.04$53KSEC
Mar 15, 2023KIDRON NADAVCEOBuy100,000$2.01$201KSEC
Mar 15, 2023Kidron MiriamExecutive OfficerSell100,000$2.01$201KSEC
Mar 15, 2023Rozov YadinDirectorBuy50,000$2.05$102KSEC
Mar 15, 2023Rozov YadinDirectorBuy20,000$1.96$39KSEC

Congress trades in ORMP Free

FiledMemberTypeAmountSource
Feb 25, 2025Brad Knott RSale$15,001 - $50,000Official filing

Questions about ORMP

Are insiders buying or selling ORMP stock?

In the last 12 months Oramed Pharmaceuticals Inc. insiders made open-market purchases worth about $0 and sales worth about $1.2 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

When was the last insider trade in ORMP?

The most recent open-market insider trade in ORMP was filed on 2026-10-02.

How many institutions own ORMP?

84 investment managers reported holding ORMP in SEC Form 13F filings for Q2 2026.

Has any member of Congress traded ORMP?

Yes. Members of Congress reported 1 trades in ORMP over the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

GGRBBDCRBGBPREREFOPTUPRTAN.A.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).